Citadel Advisors’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-14,753
| Closed | -$45K | – | 5382 |
|
|
2019
Q3 | $45K | Buy |
+14,753
| New | +$45K | ﹤0.01% | 4378 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5346 |
|
|
2019
Q1 | – | Sell |
-14,980
| Closed | -$54K | – | 5284 |
|
|
2018
Q4 | $54K | Sell |
14,980
-526,832
| -97% | -$1.9M | ﹤0.01% | 4099 |
|
|
2018
Q3 | $3.1M | Buy |
541,812
+40,191
| +8% | +$230K | ﹤0.01% | 1875 |
|
|
2018
Q2 | $2.51M | Buy |
501,621
+486,785
| +3,281% | +$2.44M | ﹤0.01% | 1967 |
|
|
2018
Q1 | $76K | Buy |
+14,836
| New | +$76K | ﹤0.01% | 3683 |
|
|
2017
Q2 | – | Sell |
-29,506
| Closed | -$146K | – | 4393 |
|
|
2017
Q1 | $146K | Buy |
29,506
+12,645
| +75% | +$62.6K | ﹤0.01% | 3268 |
|
|
2016
Q4 | $187K | Buy |
+16,861
| New | +$187K | ﹤0.01% | 3091 |
|